RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announces the sale of Excelsior Medical Corporation to ICU Medical, Inc. ICU Medical develops, manufactures and sells medical technologies used in infusion therapy, oncology and critical care applications.
Excelsior, based in Neptune, N.J., is a leading provider of intraluminal catheter care and disinfection products. The company's goal is to help clinicians reduce the risk of infection, avoid medication errors and lower healthcare costs. Excelsior has developed and commercialized the innovative SwabCap® and SwabFlush™ products, and is a leader in pre-filled saline and heparin flush syringes. The company also manufactures and sells pharmacy filling and syringe infusion pump and tubing systems. In connection with this transaction, ICU Medical has agreed to sell the pre-filled syringe and SwabFlush™ businesses to Medline Industries, Inc. ICU Medical will retain the SwabCap® and pumps and tubing businesses.
"Excelsior's management team has done an excellent job of building a fully-integrated platform in intraluminal catheter care," says Lester B. Knight, founding partner of RoundTable and chairman of Excelsior. "We believe that ICU Medical and Medline will be strong strategic partners for the company, its employees, and customers going forward."
Steve Thornton, CEO of Excelsior Medical Corporation, says, "RoundTable has been a tremendous partner for Excelsior since their initial acquisition of the Company in 2004. They have provided key access to customers and helped expand our product offerings. We look forward to partnering with ICU Medical and Medline to continue to achieve our growth objectives."
Robert W. Baird & Co. acted as exclusive financial advisor to Excelsior Medical Corporation and Sidley Austin LLP acted as exclusive legal advisor to RoundTable in this transaction.
Source: RoundTable Healthcare Partners
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.